T. Rowe Price Associates’s Celcuity CELC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$107M Sell
1,025,837
-253,979
-20% -$29.3M 0.01% 680
2026
Q1
$146M Buy
1,279,816
+39,535
+3% +$4.31M 0.02% 533
2025
Q4
$124M Buy
1,240,281
+642,125
+107% +$52.8M 0.01% 586
2025
Q3
$29.6M Buy
598,156
+582,970
+3,839% +$23.3M ﹤0.01% 957
2025
Q2
$203K Buy
15,186
+1,054
+7% +$11.5K ﹤0.01% 2706
2025
Q1
$143K Buy
14,132
+1,411
+11% +$16K ﹤0.01% 2743
2024
Q4
$167K Buy
+12,721
New +$179K ﹤0.01% 2746

Other funds holding CELC

T. Rowe Price Associates's CELC Position: Q2 2026 in Review

T. Rowe Price Associates reduced its Celcuity (CELC) stake by 20% in Q2 2026, selling an estimated $29.3M and leaving 1,025,837 shares worth $107M. The position accounts for 0.01% of the portfolio, ranked #680.

T. Rowe Price Associates first reported a position in CELC in Q4 2024 and has held it in 7 quarters since. The position peaked at $146M in Q1 2026. 274 funds tracked by Wall St. Rank hold CELC as of Q2 2026.

  • T. Rowe Price Associates held 1,025,837 shares of Celcuity worth $107M as of Q2 2026.
  • T. Rowe Price Associates sold 253,979 Celcuity shares in Q2 2026, an estimated $29.3M.
  • Celcuity made up 0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #680 holding.
  • T. Rowe Price Associates first reported a position in Celcuity in Q4 2024 and has held it in 7 quarters since.
  • T. Rowe Price Associates's Celcuity position peaked at $146M in Q1 2026.
  • 274 funds tracked by Wall St. Rank held Celcuity as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.